UX111
ABT-001
Phase 3 mab active
Quick answer
UX111 for MPS IIIA is a Phase 3 program (mab) at ABEONA THERAPEUTICS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ABEONA THERAPEUTICS INC.
- Indication
- MPS IIIA
- Phase
- Phase 3
- Modality
- mab
- Status
- active